PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 78 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $532,000 | +57.4% | 175,624 | +96.2% | 0.01% | +66.7% |
Q4 2021 | $338,000 | +704.8% | 89,524 | +715.3% | 0.00% | – |
Q2 2021 | $42,000 | -87.3% | 10,980 | -89.7% | 0.00% | -100.0% |
Q2 2020 | $332,000 | +260.9% | 107,000 | +321.3% | 0.00% | +100.0% |
Q4 2019 | $92,000 | -92.0% | 25,400 | -92.4% | 0.00% | -94.1% |
Q3 2019 | $1,148,000 | +128.2% | 336,400 | +124.3% | 0.03% | +100.0% |
Q1 2019 | $503,000 | +26.1% | 150,000 | 0.0% | 0.02% | +13.3% |
Q4 2018 | $399,000 | -82.2% | 150,000 | -62.5% | 0.02% | -85.0% |
Q3 2018 | $2,240,000 | -46.7% | 400,000 | -51.7% | 0.10% | -56.1% |
Q2 2018 | $4,201,000 | -25.8% | 828,600 | -0.2% | 0.23% | -46.4% |
Q1 2018 | $5,665,000 | +11.2% | 830,637 | +23.1% | 0.42% | +1.9% |
Q4 2017 | $5,096,000 | +22.0% | 675,000 | -6.9% | 0.42% | +9.4% |
Q3 2017 | $4,176,000 | +1.9% | 725,000 | -10.5% | 0.38% | -9.9% |
Q2 2017 | $4,099,000 | – | 810,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
Annandale Capital, LLC | 67,000 | $70 | 0.02% |
WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
Sigma Planning Corp | 343,934 | $357,691 | 0.01% |